- Simulation Products
- BodyWorks Eve
- ORSIM Bronchoscopy Simulator
- Support Plans
- AI Software
The following information is disclosed in accordance with Rule 26 of the AIM regulations Last updated: 6 July 2017.
MedaPhor Group plc is incorporated and registered in England and Wales under the Companies Act 2006 with registered number 09028611. Our registered office is The Medicentre, Heath Park, Cardiff, Wales CF14 4UJ. The main country of operation is the UK.
MedaPhor Group plc is headquartered in Cardiff, UK and has offices in Oxford, UK and Alpharetta, GA, USA. The Group’s customers are some of the world’s leading medical institutions. Our guiding principle is to develop world-class ultrasound software and simulation technologies that will improve the quality and speed of ultrasound scanning in the clinical environment.
MedaPhor Group plc was admitted to the Alternative Investment Market (AIM) of the London Stock Exchange on 27 August 2014.
For information about the Directors and Committees, click here
Click here for more information about the number of securities in issue and, insofar as the Company is aware, the percentage of AIM securities not in public hands, together with the identity and percentage of significant shareholders.
For access to the company’s Annual and Half-yearly reports, click here
Click here to access the Admission
Document in respect of the company’s admission to AIM on 27th August 2014
Click here for details of the Company’s advisors.
The Board is accountable to the Company’s shareholders for maintaining high standards of Corporate Governance. The Directors acknowledge the principles set out in the Combined Code issued by the committee on Corporate Governance, although it does not comply with the Combined Code itself. The Board are committed to maintaining a high level of corporate governance in so far as it considered to be appropriate for a smaller quoted (AIM-listed) company.
MedaPhor Group plc is subject to the UK City Code on Takeovers and Mergers